Time-driven activity-based costing analysis of panretinal photocoagulation shows 47.8% of cases have a negative margin relative to maximum Medicare reimbursement, with large financial disincentives for bilateral cases, which may disincentivize high-value care for vulnerable patients.
Keywords: Cost; Diabetic Retinopathy; Panretinal Photocoagulation; Retina.
Copyright © 2025. Published by Elsevier Inc.